Back to results
US 2026/0209330 A1Published application
S100a7 as a diagnostic marker and therapeutic target for disorders
AssigneeOhio State Innovation Foundation
InventorsRamesh GANJU, Sanjay MISHRA, Manish CHARAN
Life of this patent
Estimating the term…
Abstract
The present disclosures relates to S100A7 inhibitors and uses thereof for treatment of obesity or obesity-associated diseases. The present disclosures also relates to S100A7 as a biomarker for diagnosing, monitoring, and/or treating obesity or obesity-associated diseases.
Claims22
A recombinant antibody that specifically binds to a S100A7 polypeptide.
-23. (canceled)
A method of treating obesity or an obesity-associated disorder in a subject in need thereof comprising:
- determining if the subject has obesity or an obesity-associated disorder;
- and
- administering to the subject a therapeutically effective amount of an S100A7 inhibitor if the subject is determined to have obesity or an obesity-associated disorder.
-82. (canceled)
Dependencies are inferred from the claim text.